Medidata announced that Ergomed's Rare Disease Innovation CenterTM will leverage Medidata's Patient Cloud, Intelligent Trials technologies, and Synthetic Control Arm? to help sponsors reduce clinical trial timelines, optimize patient experiences, and bring effective rare disease therapies to market more quickly. Patient Cloud's suite of powerful solutions increases patient engagement while reducing participation burdens, thereby enabling the Center to address a common challenge of enrolling patients with rare diseases in clinical trials.

Built into the Medidata Clinical Cloud platform, Patient Cloud solutions combine Medidata's leading clinical trial technology with unmatched patient centricity by design. Intelligent Trials provides advanced analytics to improve the speed, success, and quality of trials. Built on a foundation of data from more than 27,000 clinical trials and 8+ million patients across more than 140 countries, Intelligent Trials help to optimize trial planning, site selection, and enrollment decisions, and provide live insights into clinical studies.